Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3217840
Max Phase: Preclinical
Molecular Formula: C35H35N7O4
Molecular Weight: 617.71
Molecule Type: Protein
Associated Items:
ID: ALA3217840
Max Phase: Preclinical
Molecular Formula: C35H35N7O4
Molecular Weight: 617.71
Molecule Type: Protein
Associated Items:
Canonical SMILES: N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1ccccc1
Standard InChI: InChI=1S/C35H35N7O4/c36-28(16-25-19-37-21-40-25)33(43)41-31(14-23-17-38-29-12-6-4-10-26(23)29)34(44)42-32(35(45)46-20-22-8-2-1-3-9-22)15-24-18-39-30-13-7-5-11-27(24)30/h1-13,17-19,21,28,31-32,38-39H,14-16,20,36H2,(H,37,40)(H,41,43)(H,42,44)/t28-,31-,32-/m0/s1
Standard InChI Key: CEGRLYSQYGXBTQ-MHDHXZMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 617.71 | Molecular Weight (Monoisotopic): 617.2751 | AlogP: 3.44 | #Rotatable Bonds: 13 |
Polar Surface Area: 170.78 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.00 | CX Basic pKa: 7.70 | CX LogP: 2.96 | CX LogD: 2.44 |
Aromatic Rings: 6 | Heavy Atoms: 46 | QED Weighted: 0.11 | Np Likeness Score: -0.13 |
1. Liu L, Wei L, Yang Y, Zhao M, Zhang X, Zheng M, Wang Y, Peng S. (2011) A class of novel AA-Trp-Trp-OBzl: synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and intercalation mechanism, 2 (2): [10.1039/C0MD00208A] |
Source(1):